Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting

Reuters

Mar 04

Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting

Autonomix Medical Inc. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the Cardiovascular Research Technologies $(CRT)$ 2026 Meeting in Washington, DC, taking place March 7-10, 2026. The presentation is scheduled for Saturday, March 7, 2026, from 2:18–2:24 p.m. ET during the Top Abstract Session (S194) in the Hypertension Therapies and Renal Denervation session. Links: https://www.globenewswire.com/Tracker?data=8EfhO01BFuy4XexpqANHDCAKiShTPDOmueQt1hGjXL8lxgFX8F-kHMUTZ-MeFNo6LfefP3aMwOfkjOe2eHrOlLjolC2PV93DR93q4XcKPu8pyTOnEZEaD2HwihPULQ3E-m9UZASkAbmDDeNxJ33Ycg== ; https://www.globenewswire.com/Tracker?data=GNy2v1CmvLgJ5V2kFByhwFRjbJE8TW9P7MWe7BCaRmbeIaBZpfXSB7qKboM7BDFtp3WNJug-WE0YmLdW3JU0QA==

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040840PRIMZONEFULLFEED9665419) on March 04, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2616360555"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616360555\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616360555?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616360555","market":"us","top_or_hot":-1,"title":"Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AMIX\">Autonomix Medical Inc</a>. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the Cardiovascular Research Technologies <a href=\"https://laohu8.com/S/CRT\">$(CRT)$</a> 2026 Meeting in Washington, DC, taking place March 7-10, 2026. The presentation is scheduled for Saturday, March 7, 2026, from 2:18–2:24 p.m. ET during the Top Abstract Session (S194) in the Hypertension Therapies and Renal Denervation session. Links: https://www.globenewswire.com/Tracker?data=8EfhO01BFuy4XexpqANHDCAKiShTPDOmueQt1hGjXL8lxgFX8F-kHMUTZ-MeFNo6LfefP3aMwOfkjOe2eHrOlLjolC2PV93DR93q4XcKPu8pyTOnEZEaD2HwihPULQ3E-m9UZASkAbmDDeNxJ33Ycg== ; https://www.globenewswire.com/Tracker?data=GNy2v1CmvLgJ5V2kFByhwFRjbJE8TW9P7MWe7BCaRmbeIaBZpfXSB7qKboM7BDFtp3WNJug-WE0YmLdW3JU0QA==\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040840PRIMZONEFULLFEED9665419) on March 04, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAutonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-04 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AMIX\">Autonomix Medical Inc</a>. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the Cardiovascular Research Technologies <a href=\"https://laohu8.com/S/CRT\">$(CRT)$</a> 2026 Meeting in Washington, DC, taking place March 7-10, 2026. The presentation is scheduled for Saturday, March 7, 2026, from 2:18–2:24 p.m. ET during the Top Abstract Session (S194) in the Hypertension Therapies and Renal Denervation session. Links: https://www.globenewswire.com/Tracker?data=8EfhO01BFuy4XexpqANHDCAKiShTPDOmueQt1hGjXL8lxgFX8F-kHMUTZ-MeFNo6LfefP3aMwOfkjOe2eHrOlLjolC2PV93DR93q4XcKPu8pyTOnEZEaD2HwihPULQ3E-m9UZASkAbmDDeNxJ33Ycg== ; https://www.globenewswire.com/Tracker?data=GNy2v1CmvLgJ5V2kFByhwFRjbJE8TW9P7MWe7BCaRmbeIaBZpfXSB7qKboM7BDFtp3WNJug-WE0YmLdW3JU0QA==\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040840PRIMZONEFULLFEED9665419) on March 04, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3QW5Z07.USD","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLc6kQL4:1","article_id":"2616360555","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616360555","pubTimestamp":1772631616,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting               Autonomix Medical Inc. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the C","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","BK4588":"碎股","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","BK4112":"金融交易所和数据","NDAQ":"纳斯达克OMX交易所","BK4585":"ETF&股票定投概念","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4082":"医疗保健设备","AMIX":"Autonomix Medical Inc","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC"},"translate_title":"Autonomix Medical将在CRT 2026会议上展示顶级摘要讲台","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMIX":0.9,"NDAQ":0.9},"content_text":"Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting\n    \n\nAutonomix Medical Inc. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the Cardiovascular Research Technologies $(CRT)$ 2026 Meeting in Washington, DC, taking place March 7-10, 2026. The presentation is scheduled for Saturday, March 7, 2026, from 2:18–2:24 p.m. ET during the Top Abstract Session (S194) in the Hypertension Therapies and Renal Denervation session. Links: https://www.globenewswire.com/Tracker?data=8EfhO01BFuy4XexpqANHDCAKiShTPDOmueQt1hGjXL8lxgFX8F-kHMUTZ-MeFNo6LfefP3aMwOfkjOe2eHrOlLjolC2PV93DR93q4XcKPu8pyTOnEZEaD2HwihPULQ3E-m9UZASkAbmDDeNxJ33Ycg== ; https://www.globenewswire.com/Tracker?data=GNy2v1CmvLgJ5V2kFByhwFRjbJE8TW9P7MWe7BCaRmbeIaBZpfXSB7qKboM7BDFtp3WNJug-WE0YmLdW3JU0QA==\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040840PRIMZONEFULLFEED9665419) on March 04, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}